Published on 7 Oct 2024 on GuruFocus.com · via Yahoo Finance
Revenue: $83 million, exceeding guidance range of $80 million to $82 million.Non-GAAP EBITDA: $11.7 million, above guidance range of $10.5 million to $11.5 million.Retail Vertical Revenue: 32.2% of total revenue, grew 8.7% sequentially and 2.9% year-over-year.TMT Vertical Revenue: 28% of total revenue, decreased 3.3% sequentially and 3.6% year-over-year.CPG and Manufacturing Revenue: 11.9% of total revenue, increased 3% sequentially, decreased 9.5% year-over-year.Healthcare and Pharma Revenue: 3.8% of total revenue, increased 5% sequentially, decreased 14.8% year-over-year.Gross Profit (GAAP): $29.6 million or 35.6% of revenue.Gross Profit (Non-GAAP): $30.1 million or 36.2% of revenue.GAAP Net Loss: $0.8 million or $0.01 per share.Non-GAAP Net Income: $6 million or $0.08 per share.Cash and Cash Equivalents: $256 million as of June 30, 2024.Total Headcount: 3,961 employees.Third Quarter Revenue Guidance: $84 million to $86 million.Third Quarter Non-GAAP EBITDA Guidance: $12.3 million to $13.3 million.
Warning! GuruFocus has detected 7 Warning Signs with GDYN.